Equities research analysts expect Colgate-Palmolive (NYSE:CL) to report $0.75 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Eight analysts have made estimates for Colgate-Palmolive’s earnings, with estimates ranging from $0.74 to $0.76. Colgate-Palmolive also posted earnings of $0.75 per share in the same quarter last year. The firm is expected to announce its next earnings report on Friday, January 26th.
According to Zacks, analysts expect that Colgate-Palmolive will report full year earnings of $2.88 per share for the current fiscal year, with EPS estimates ranging from $2.86 to $2.95. For the next financial year, analysts anticipate that the firm will report earnings of $3.09 per share, with EPS estimates ranging from $3.01 to $3.15. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Colgate-Palmolive.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. Colgate-Palmolive’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same period last year, the company posted $0.73 EPS.
Several analysts have commented on the stock. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, October 17th. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Monday, October 16th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective on the stock in a report on Tuesday. Deutsche Bank started coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective on the stock. Finally, SunTrust Banks upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and lifted their price objective for the company from $65.00 to $85.00 in a report on Wednesday, October 11th. Three investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $76.33.
Shares of Colgate-Palmolive (NYSE:CL) traded up $0.86 during trading hours on Friday, hitting $74.85. 4,352,200 shares of the company were exchanged, compared to its average volume of 3,605,025. The firm has a market cap of $64,971.00, a P/E ratio of 25.78, a price-to-earnings-growth ratio of 3.39 and a beta of 0.81. The company has a quick ratio of 0.92, a current ratio of 1.23 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27.
In other news, COO Justin Skala sold 126,393 shares of the business’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the sale, the chief operating officer now directly owns 262,361 shares in the company, valued at $19,144,482.17. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the business’s stock in a transaction dated Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total value of $539,702.50. Following the sale, the insider now owns 38,691 shares in the company, valued at $2,831,407.38. The disclosure for this sale can be found here. Insiders have sold 181,048 shares of company stock valued at $13,168,995 in the last three months. Insiders own 1.02% of the company’s stock.
Hedge funds have recently made changes to their positions in the stock. Pacer Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 8.4% during the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after buying an additional 1,566 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Colgate-Palmolive by 4.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock worth $139,014,000 after buying an additional 77,414 shares in the last quarter. Israel Discount Bank of New York bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $1,349,000. Principal Financial Group Inc. boosted its holdings in shares of Colgate-Palmolive by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock worth $93,025,000 after buying an additional 7,905 shares in the last quarter. Finally, Personal Capital Advisors Corp boosted its holdings in shares of Colgate-Palmolive by 5.8% during the 2nd quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock worth $29,209,000 after buying an additional 21,456 shares in the last quarter. Institutional investors and hedge funds own 72.84% of the company’s stock.
WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/12/zacks-brokerages-anticipate-colgate-palmolive-cl-will-post-earnings-of-0-75-per-share.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Get a free copy of the Zacks research report on Colgate-Palmolive (CL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.